We provide the first evidence that LIMK1 is a novel kinase that, in synergy with CDK5, is responsible for phosphorylating β‐catenin at S191, leading to β‐catenin nuclear translocation and ultimately promoting ESCC metastasis. Here, CDK5 is linked to esophageal squamous cell carcinoma.